About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 516042, 11 pages
http://dx.doi.org/10.1155/2011/516042
Review Article

Immunodiagnosis of Neurocysticercosis: Ways to Focus on the Challenge

Departamento de Immunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), A.P. 70228, Ciudad Universitaria, C.P. 04510 México City, DF, Mexico

Received 1 June 2011; Revised 22 August 2011; Accepted 23 August 2011

Academic Editor: Luis I. Terrazas

Copyright © 2011 M. Esquivel-Velázquez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. H. García, A. E. Gonzalez, C. A. W. Evans, and R. H. Gilman, “Taenia solium cysticercosis,” The Lancet, vol. 362, no. 9383, pp. 547–556, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. A. C. White, “Neurocysticercosis: a major cause of neurological disease worldwide,” Clinical Infectious Diseases, vol. 24, no. 2, pp. 101–115, 1997. View at Scopus
  3. World Health Organization (WHO), “Control of neurocysticercosis,” in Proceedings of the 55th World Health Assembly, April 2002, Provisional Agenda Item 13.18.
  4. B. O. Colli, N. Martelli, J. A. A. Júnior et al., “Cysticercosis of the central nervous system. I. Surgical treatment of cerebral cysticercosis: a 23 years experience in the Hospital das Clínicas of Ribeirão Preto Medical School,” Arquivos de Neuro-Psiquiatria, vol. 52, no. 2, pp. 166–186, 1994. View at Scopus
  5. R. H. S. Peralta, A. J. Vaz, A. Pardini et al., “Evaluation of an antigen from Taenia crassiceps cysticercus for the serodiagnosis of neurocysticercosis,” Acta Tropica, vol. 83, no. 2, pp. 159–168, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Rajshekhar, G. Chacko, R. P. Haran, M. J. Chandy, and S. M. Chandi, “Clinicoradiological and pathological correlations in patients with solitary cysticercus granuloma and epilepsy: focus on presence of the parasite and oedema formation,” Journal of Neurology Neurosurgery and Psychiatry, vol. 59, no. 3, pp. 284–286, 1995.
  7. A. Fleury, J. Morales, R. J. Bobes et al., “An epidemiological study of familial neurocysticercosis in an endemic Mexican community,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 100, no. 6, pp. 551–558, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. A. Fleury, M. Hernández, G. Fragoso, R. M. E. Parkhouse, L. J. S. Harrison, and E. Sciutto, “Detection of secreted cysticercal antigen: a useful tool in the diagnosis of inflammatory neurocysticercosis,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 97, no. 5, pp. 542–546, 2003. View at Publisher · View at Google Scholar
  9. H. H. Garcia and O. H. Del Brutto, “Neurocysticercosis: updated concepts about an old disease,” The Lancet Neurology, vol. 4, no. 10, pp. 653–661, 2005. View at Publisher · View at Google Scholar · View at PubMed
  10. P. Salgado, R. Rojas, and J. Sotelo, “Cysticercosis: clinical classification based on imaging studies,” Archives of Internal Medicine, vol. 157, no. 17, pp. 1991–1997, 1997.
  11. E. Sciutto, G. Fragoso, A. Fleury et al., “Taenia solium disease in humans and pigs: an ancient parasitosis disease rooted in developing countries and emerging as a major health problem of global dimensions,” Microbes and Infection, vol. 2, no. 15, pp. 1875–1890, 2000. View at Publisher · View at Google Scholar
  12. J. Sotelo and A. Flisser, “Neurocysticercosis. Practical treatment guidelines,” CNS Drugs, vol. 7, no. 1, pp. 17–25, 1997.
  13. A. Carpio, “Diagnostic criteria for human cysticercosis,” Journal of the Neurological Sciences, vol. 161, no. 2, pp. 185–188, 1998.
  14. E. Sarti, P. M. Schantz, A. Plancarte et al., “Epidemiological investigation of Taenia solium taeniasis and cysticercosis in a rural village of Michoacan State, Mexico,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 88, no. 1, pp. 49–52, 1994. View at Publisher · View at Google Scholar
  15. R. J. Bobes, M. Hernández, C. Márquez et al., “Subarachnoidal and intraventricular human neurocysticercosis: application of an antigen detection assay for the diagnosis and follow-up,” Tropical Medicine and International Health, vol. 11, no. 6, pp. 943–950, 2006. View at Publisher · View at Google Scholar · View at PubMed
  16. E. C. Bueno, C. M. Scheel, A. J. Vaz et al., “Application of synthetic 8-kD and recombinant GP50 antigens in the diagnosis of neurocysticercosis by enzyme-linked immunosorbent assay,” American Journal of Tropical Medicine and Hygiene, vol. 72, no. 3, pp. 278–283, 2005.
  17. J. Y. Chung, Y. Y. Bahk, S. Huh, S. Y. Kong, Y. Kong, and S. Y. Cho, “A recombinant 10-kDa protein of Taenia solium metacestodes specific to active neurocysticercosis,” Journal of Infectious Diseases, vol. 180, no. 4, pp. 1307–1315, 1999. View at Publisher · View at Google Scholar · View at PubMed
  18. E. Ferrer, P. Bonay, M. Foster-Cuevas et al., “Molecular cloning and characterisation of Ts8B1, Ts8B2 and Ts8B3, three new members of the Taenia solium metacestode 8 kDa diagnostic antigen family,” Molecular and Biochemical Parasitology, vol. 152, no. 1, pp. 90–100, 2007. View at Publisher · View at Google Scholar · View at PubMed
  19. R. M. Greene, K. Hancock, P. P. Wilkins, and V. C. W. Tsang, “Taenia solium: molecular cloning and serologic evaluation of 14- and 18-kDa related, diagnostic antigens,” Journal of Parasitology, vol. 86, no. 5, pp. 1001–1007, 2000.
  20. K. Hancock, A. Khan, F. B. Williams et al., “Characterization of the 8-kilodalton antigens of Taenia solium metacestodes and evaluation of their use in an enzyme-linked immunosorbent assay for serodiagnosis,” Journal of Clinical Microbiology, vol. 41, no. 6, pp. 2577–2586, 2003.
  21. K. Hancock, S. Pattabhi, R. M. Greene et al., “Characterization and cloning of GP50, a Taenia solium antigen diagnostic for cysticercosis,” Molecular and Biochemical Parasitology, vol. 133, no. 1, pp. 115–124, 2004. View at Publisher · View at Google Scholar
  22. K. Hancock, S. Pattabhi, F. W. Whitfield et al., “Characterization and cloning of T24, a Taenia solium antigen diagnostic for cysticercosis,” Molecular and Biochemical Parasitology, vol. 147, no. 1, pp. 109–117, 2006. View at Publisher · View at Google Scholar · View at PubMed
  23. R. C. R. Hell, P. Amim, H. M. de Andrade et al., “Immunodiagnosis of human neurocysticercosis using a synthetic peptide selected by phage-display,” Clinical Immunology, vol. 131, no. 1, pp. 129–138, 2009. View at Publisher · View at Google Scholar · View at PubMed
  24. M. Hernández, C. Beltrán, E. García et al., “Cysticercosis: towards the design of a diagnostic kit based on synthetic peptides,” Immunology Letters, vol. 71, no. 1, pp. 13–17, 2000. View at Publisher · View at Google Scholar
  25. E. G. Lee, M. Y. Lee, J. Y. Chung et al., “Feasibility of baculovirus-expressed recombinant 10-kDa antigen in the serodiagnosis of Taenia solium neurocysticercosis,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 99, no. 12, pp. 919–926, 2005. View at Publisher · View at Google Scholar · View at PubMed
  26. M. O. Sato, Y. Sako, M. Nakao, H. Yamasaki, K. Nakaya, and A. Ito, “Evaluation of purified Taenia solium glycoproteins and recombinant antigens in the serologic detection of human and swine cysticercosis,” Journal of Infectious Diseases, vol. 194, no. 12, pp. 1783–1790, 2006. View at Publisher · View at Google Scholar · View at PubMed
  27. M. R. M. da Silva, A. A. M. Maia, N. M. Espíndola, L. D. R. Machado, A. J. Vaz, and F. Henrique-Silva, “Recombinant expression of Taenia solium TS14 antigen and its utilization for immunodiagnosis of neurocysticercosis,” Acta Tropica, vol. 100, no. 3, pp. 192–198, 2006. View at Publisher · View at Google Scholar · View at PubMed
  28. L. Salim, A. Ang, S. Handali, and V. C. W. Tsang, “Seroepidemiologic survey of cysticercosis-taeniasis in four central highland districts of papua, indonesia,” American Journal of Tropical Medicine and Hygiene, vol. 80, no. 3, pp. 384–388, 2009.
  29. C. M. Scheel, A. Khan, K. Hancock et al., “Serodiagnosis of neurocysticercosis using synthetic 8-KD proteins: comparison of assay formats,” American Journal of Tropical Medicine and Hygiene, vol. 73, no. 4, pp. 771–776, 2005.
  30. S. R. V. Atluri, P. Singhi, N. Khandelwal, and N. Malla, “Evaluation of excretory secretory and 10–30 kDa antigens of Taenia solium cysticerci by EITB assay for the diagnosis of neurocysticercosis: brief definitive report,” Parasite Immunology, vol. 31, no. 3, pp. 151–155, 2009. View at Publisher · View at Google Scholar · View at PubMed
  31. S. R. V. Atluri, P. Singhi, N. Khandelwal, and N. Malla, “Neurocysticercosis immunodiagnosis using Taenia solium cysticerci crude soluble extract, excretory secretory and lower molecular mass antigens in serum and urine samples of Indian children,” Acta Tropica, vol. 110, no. 1, pp. 22–27, 2009. View at Publisher · View at Google Scholar · View at PubMed
  32. Y. Castillo, S. Rodriguez, H. H. García et al., “Urine antigen detection for the diagnosis of human neurocysticercosis,” American Journal of Tropical Medicine and Hygiene, vol. 80, no. 3, pp. 379–383, 2009.
  33. N. Malla, R. Kaur, N. K. Ganguly, I. M. Sawhney, and R. C. Mahajan, “Utility of specific IgG4 response in saliva and serum samples for the diagnosis and follow up of human neurocysticercosis,” Nepal Medical College Journal, vol. 7, no. 1, pp. 1–9, 2005.
  34. A. Flisser and T. W. Gyorkos, “Contribution of immunodiagnostic tests to epidemiological/intervention studies of cysticercosis/taeniosis in México,” Parasite Immunology, vol. 29, no. 12, pp. 637–649, 2007. View at Publisher · View at Google Scholar · View at PubMed
  35. V. Prabhakaran, V. Rajshekhar, K. D. Murrell, and A. Oommen, “Conformation-sensitive immunoassays improve the serodiagnosis of solitary cysticercus granuloma in Indian patients,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 101, no. 6, pp. 570–577, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. M. Ramos-Kuri, R. M. Montoya, A. Padilla et al., “Immunodiagnosis of neurocysticercosis: disappointing performance of serology (enzyme-linked immunosorbent assay) in an unbiased sample of neurological patients,” Archives of Neurology, vol. 49, no. 6, pp. 633–636, 1992. View at Scopus
  37. S. J. Furrows, J. McCroddan, W. J. Bligh, and P. Chiodini, “Lack of specificity of a single positive 50-kDa band in the electroimmunotransfer blot (EITB) assay for cysticercosis,” Clinical Microbiology and Infection, vol. 12, no. 5, pp. 459–462, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. A. Fleury, A. Dessein, P. M. Preux et al., “Symptomatic human neurocysticercosis: age, sex and exposure factors relating with disease heterogeneity,” Journal of Neurology, vol. 251, no. 7, pp. 830–837, 2004. View at Scopus
  39. J. Morales-Montor, A. Chavarria, M. A. De León et al., “Host gender in parasitic infections of mammals: an evaluation of the female host supremacy paradigm,” Journal of Parasitology, vol. 90, no. 3, pp. 531–546, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. J. Morales-Montor, S. Baig, C. Hallal-Calleros, and R. T. Damian, “Taenia crassiceps: androgen reconstitution of the host leads to protection during cysticercosis,” Experimental Parasitology, vol. 100, no. 4, pp. 209–216, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. I. Marriott and Y. M. Huet-Hudson, “Sexual dimorphism in innate immune responses to infectious organisms,” Immunologic Research, vol. 34, no. 3, pp. 177–192, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. A. Chavarría, A. Fleury, E. García, C. Márquez, G. Fragoso, and E. Sciutto, “Relationship between the clinical heterogeneity of neurocysticercosis and the immune-inflammatory profiles,” Clinical Immunology, vol. 116, no. 3, pp. 271–278, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. O. H. Del Brutto, E. Garcia, O. Talamas, and J. Sotelo, “Sex-related severity of inflammation in parenchymal brain cysticercosis,” Archives of Internal Medicine, vol. 148, no. 3, pp. 544–546, 1988. View at Scopus
  44. A. Fleury, T. Gomez, I. Alvarez et al., “High prevalence of calcified silent neurocysticercosis in a rural village of Mexico,” Neuroepidemiology, vol. 22, no. 2, pp. 139–145, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. D. Verthelyi, “Sex hormones as immunomodulators in health and disease,” International Immunopharmacology, vol. 1, no. 6, pp. 983–993, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Khurana, A. Aggarwal, and N. Malla, “Prevalence of anti-cysticercus antibodies in slum, rural and urban populations in and around Union Territory, Chandigarh,” Indian Journal of Pathology and Microbiology, vol. 49, no. 1, pp. 51–53, 2006. View at Scopus
  47. M. Tibayrenc, “Human genetic diversity and the epidemiology of parasitic and other transmissible diseases,” Advances in Parasitology, vol. 64, pp. 377–462, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. C. Alves, T. Souza, I. Meyer, M. B. P. Toralles, and C. Brites, “Immunogenetics and infectious diseases: special reference to the mayor histocompatibility complex,” Brazilian Journal of Infectious Diseases, vol. 10, no. 2, pp. 122–131, 2006. View at Scopus
  49. S. C. Shafir, F. J. Sorvillo, and L. Smith, “Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans,” Clinical Microbiology Reviews, vol. 22, no. 1, pp. 37–45, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. F. Verra, P. Avellino, G. Bancone, V. Mangano, and D. Modiano, “Genetic epidemiology of susceptibility to malaria: not only academic exercises,” Parassitologia, vol. 50, no. 1-2, pp. 147–150, 2008. View at Scopus
  51. O. H. Del Brutto, G. Granados, O. Talamas, J. Sotelo, and C. Gorodezky, “Genetic pattern of the HLA system: HLA A, B, C, DR, and DQ antigens in Mexican patients with parenchymal brain cysticercosis,” Human Biology, vol. 63, no. 1, pp. 85–93, 1991. View at Scopus
  52. G. Singh, “Neurocysticercosos in South-Central America and the Indian subcontinent. A comparative evaluation,” Arquivos de Neuro-Psiquiatria, vol. 55, no. 3, pp. 349–356, 1997. View at Scopus
  53. R. Vega, D. Piñero, B. Ramanankandrasana et al., “Population genetic structure of Taenia solium from Madagascar and Mexico: Implications for clinical profile diversity and immunological technology,” International Journal for Parasitology, vol. 33, no. 13, pp. 1479–1485, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. K. Hancock, D. E. Broughel, I. N. S. Moura et al., “Sequence variation in the cytochrome oxidase I, internal transcribed spacer 1, and Ts14 diagnostic antigen sequences of Taenia solium isolates from South and Central America, India, and Asia,” International Journal for Parasitology, vol. 31, no. 14, pp. 1601–1607, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Nakao, M. Okamoto, Y. Sako, H. Yamasaki, K. Nakaya, and A. Ito, “A phylogenetic hypothesis for the distribution of two genotypes of the pig tapeworm Taenia solium worldwide,” Parasitology, vol. 124, no. 6, pp. 657–662, 2002. View at Scopus
  56. P. Maravilla, V. Souza, A. Valera et al., “Detection of Genetic Variation in Taenia solium,” Journal of Parasitology, vol. 89, no. 6, pp. 1250–1254, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. G. Campbell, H. H. Garcia, M. Nakao, A. Ito, and P. S. Craig, “Genetic variation in Taenia solium,” Parasitology International, vol. 55, supplement, pp. S121–S126, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. R. J. Bobes, G. Fragoso, M. D. R. Reyes-Montes et al., “Genetic diversity of Taenia solium cysticerci from naturally infected pigs of central Mexico,” Veterinary Parasitology, vol. 168, no. 1-2, pp. 130–135, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. H. B. Oliveira, G. A. MacHado, M. D. R. F. Gonçalves-Pires, L. P. Moura, and J. M. Costa-Cruz, “Saline extract of Taenia saginata metacestodes as an alternative antigen for the immunodiagnosis of neurocysticercosis in human cerebrospinal fluid,” Parasitology Research, vol. 105, no. 1, pp. 169–174, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. J. V. Proaño-Narvaez, A. Meza-Lucas, O. Mata-Ruiz, R. C. García-Jerónimo, and D. Correa, “Laboratory diagnosis of human neurocysticercosis: double-blind comparison of enzyme-linked immunosorbent assay and electroimmunotransfer blot assay,” Journal of Clinical Microbiology, vol. 40, no. 6, pp. 2115–2118, 2002. View at Publisher · View at Google Scholar · View at Scopus
  61. H. H. Garcia, A. E. Gonzalez, R. H. Gilman et al., “Short report: transient antibody response in Taenia solium infection in field conditions—a major contributor to high seroprevalence,” American Journal of Tropical Medicine and Hygiene, vol. 65, no. 1, pp. 31–32, 2001. View at Scopus
  62. P. Dekumyoy, J. Waikagul, S. Vanijanonta et al., “Cysticercosis: IgG-ELISA evaluations of peak1 antigen and <30 kDa antigen of delipidized extract of Taenia solium metacestodes,” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 35, no. 1, pp. 1–9, 2004. View at Scopus
  63. B. Gottstein, V. C. W. Tsang, and P. M. Schantz, “Demonstration of species-specific and cross-reactive components of Taenia solium metacestode antigens,” American Journal of Tropical Medicine and Hygiene, vol. 35, no. 2, pp. 308–313, 1986. View at Scopus
  64. E. Hernandez-Cruz, J. J. González-Cabriales, C. Ordaz-Pichardo, N. I. De La Cruz-Hernández, and G. H. Flores-Gutiérrez, “Development of an immunobinding dot-blot assay as an alternative for the serodiagnosis of human cysticercosis,” Journal of Helminthology, vol. 83, no. 4, pp. 333–337, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. M. M. I. Ishida, G. Rubinsky-Elefant, A. W. Ferreira, S. Hoshino-Shimizu, and A. J. Vaz, “Helminth antigens (Taenia solium, Taenia crassiceps, Toxocara canis, Schistosoma mansoni and Echinococcus granulosus) and cross-reactivities in human infections and immunized animals,” Acta Tropica, vol. 89, no. 1, pp. 73–84, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. N. M. Espíndola, A. H. Iha, I. Fernandes et al., “Cysticercosis immunodiagnosis using 18- and 14-kilodalton proteins from Taenia crassiceps cysticercus antigens obtained by immunoaffinity chromatography,” Journal of Clinical Microbiology, vol. 43, no. 7, pp. 3178–3184, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. J. Mandal, P. D. Singhi, N. Khandelwal, and N. Malla, “Evaluation of lower molecular mass (20–24 kDa) Taenia solium cysticercus antigen fraction by ELISA and dot blot for the serodiagnosis of neurocysticercosis in children,” Parasitology Research, vol. 102, no. 5, pp. 1097–1101, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. G. C. Arruda, A. D. T. Da Silva, E. M. A. B. Quagliato, M. A. Maretti, and C. L. Rossi, “Evaluation of Taenia solium and Taenia crassiceps cysticercal antigens for the serodiagnosis of neurocysticercosis,” Tropical Medicine and International Health, vol. 10, no. 10, pp. 1005–1012, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. S. Rodriguez, P. Dorny, V. C. W. Tsang et al., “Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis,” Journal of Infectious Diseases, vol. 199, no. 9, pp. 1345–1352, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  70. E. C. Bueno, A. J. Vaz, L. Machado, and J. A. Livramento, “Neurocysticercosis: detection of IgG, IgA and IgE antibodies in cerebrospinal fluid, serum and saliva samples by ELISA with Taenia solium and Taenia crassiceps antigens,” Arquivos de Neuro-Psiquiatria, vol. 58, no. 1, pp. 18–24, 2000. View at Scopus
  71. H. H. Garcia, R. M. E. Parkhouse, R. H. Gilman et al., “Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 94, no. 6, pp. 673–676, 2000. View at Scopus
  72. J. A. Lopez, E. Garcia, I. M. Cortes, J. Sotelo, P. Tato, and J. L. Molinari, “Neurocysticercosis: relationship between the developmental stage of metacestode present and the titre of specific IgG in the cerebrospinal fluid,” Annals of Tropical Medicine and Parasitology, vol. 98, no. 6, pp. 569–579, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. J. L. Molinari, E. García-Mendoza, Y. De la Garza, J. A. Ramírez, J. Sotelo, and P. Tato, “Discrimination between active and inactive neurocysticercosis by metacestode excretory/secretory antigens of Taenia solium in an enzyme-linked immunosorbent assay,” American Journal of Tropical Medicine and Hygiene, vol. 66, no. 6, pp. 777–781, 2002. View at Scopus
  74. P. S. Sahu, S. C. Parija, S. K. Narayan, and D. Kumar, “Evaluation of an IgG-ELISA strategy using Taenia solium metacestode somatic and excretory-secretory antigens for diagnosis of neurocysticercosis revealing biological stage of the larvae,” Acta Tropica, vol. 110, no. 1, pp. 38–45, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  75. J. S. Grewal, S. Kaur, G. Bhatti, N. K. Ganguly, R. C. Mahajan, and N. Malla, “Kinetics of humoral and cellular immune responses in experimental cysticercosis in pigs infected with Taenia solium,” Indian Journal of Medical Research, vol. 111, pp. 43–49, 2000. View at Scopus
  76. J. P. Laclette, A. Alagon, K. Willms, and A. Torre-Blanco, “Purification of antigen B from Taenia solium cysticerci by affinity to mammalian collagen,” Journal of Parasitology, vol. 76, no. 2, pp. 273–275, 1990. View at Publisher · View at Google Scholar · View at Scopus
  77. E. C. Bueno, M. Snege, A. J. Vaz, and P. G. Leser, “Serodiagnosis of human cysticercosis by using antigens from vesicular fluid of Taenia crassiceps cysticerci,” Clinical and Diagnostic Laboratory Immunology, vol. 8, no. 6, pp. 1140–1144, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  78. E. C. Bueno, A. J. Vaz, L. Machado, J. A. Livramento, and S. R. Mielle, “Specific Taenia crassiceps and Taenia solium antigenic peptides for neurocysticercosis immunodiagnosis using serum samples,” Journal of Clinical Microbiology, vol. 38, no. 1, pp. 146–151, 2000. View at Scopus
  79. M. M. I. Ishida, R. H. S. Peralta, J. A. Livramento, S. Hoshino-Shimizu, J. M. Peralta, and A. J. Vaz, “Serodiagnosis of neurocysticercosis in patients with epileptic seizure using ELISA and immunoblot assay,” Revista do Instituto de Medicina Tropical de Sao Paulo, vol. 48, no. 6, pp. 343–346, 2006. View at Publisher · View at Google Scholar · View at Scopus
  80. H. B. Oliveira, G. A. Machado, D. D. Cabral, and J. M. Costa-Cruz, “Application of Taenia saginata metacestodes as an alternative antigen for the serological diagnosis of human neurocysticercosis,” Parasitology Research, vol. 101, no. 4, pp. 1007–1013, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  81. N. Shukla, N. Husain, Jyotsna, S. Gupta, and M. Husain, “Comparisons between scolex and membrane antigens of Cysticercus fasciolaris and Cysticercus cellulosae larvae for immunodiagnosis of neurocysticercosis,” Journal of Microbiology, Immunology and Infection, vol. 41, no. 6, pp. 519–524, 2008. View at Scopus
  82. B. Espinoza, G. Ruiz-Palacios, and A. Tovar, “Characterization by enzyme-linked immunosorbent assay of the humoral immune response in patients with neurocysticercosis and its application in immunodiagnosis,” Journal of Clinical Microbiology, vol. 24, no. 4, pp. 536–541, 1986.
  83. E. Garcia, G. Ordonez, and J. Sotelo, “Antigens from Taenia crassiceps cysticerci used in complement fixation, enzyme-linked immunosorbent assay, and Western blot (immunoblot) for diagnosis of neurocysticercosis,” Journal of Clinical Microbiology, vol. 33, no. 12, pp. 3324–3325, 1995. View at Scopus
  84. V. C. W. Tsang, J. A. Brand, and A. E. Boyer, “An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium),” Journal of Infectious Diseases, vol. 159, no. 1, pp. 50–59, 1989. View at Scopus
  85. O. H. Del Brutto, R. Santibanez, C. A. Noboa, R. Aguirre, E. Diaz, and T. A. Alarcon, “Epilepsy due to neurocysticercosis: analysis of 203 patients,” Neurology, vol. 42, no. 2, pp. 389–392, 1992. View at Scopus
  86. V. Prabhakaran, V. Rajshekhar, K. D. Murrell, and A. Oommen, “Taenia solium metacestode glycoproteins as diagnostic antigens for solitary cysticercus granuloma in Indian patients,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 98, no. 8, pp. 478–484, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  87. F. Aguilar-Rebolledo, A. Meza-Lucas, J. Torres et al., “Evaluation of the enzyme-linked immunoelectrotransfer blot assay for diagnosis of neurocysticercosis in children,” Journal of Child Neurology, vol. 17, no. 6, pp. 416–420, 2002. View at Scopus
  88. E. Santamaría, A. Plancarte, and A. S. De Aluja, “The experimental infection of pigs with different numbers of Taenia solium eggs: immune response and efficiency of establishment,” Journal of Parasitology, vol. 88, no. 1, pp. 69–73, 2002. View at Scopus
  89. A. C. White and H. H. Garcia, “Recent developments in the epidemiology, diagnosis, treatment, and prevention of neurocysticercosis,” Current Infectious Disease Reports, vol. 1, no. 5, pp. 434–440, 1999.
  90. J. Mandal, P. D. Singhi, N. Khandelwal, and N. Malla, “Evaluation of ELISA and dot blots for the serodiagnosis of neurocysticercosis, in children found to have single or multiple enhancing lesions in computerized tomographic scans of the brain,” Annals of Tropical Medicine and Parasitology, vol. 100, no. 1, pp. 39–48, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  91. M. K. Katti and E. C. Bueno, “Are alternative sources of parasitic (cysticercal) antigens necessary for diagnosis of neurocysticercosis?” Journal of Clinical Microbiology, vol. 38, no. 9, pp. 3524–3525, 2000. View at Scopus
  92. M. Feldman, A. Plancarte, M. Sandoval, M. Wilson, and A. Flisser, “Comparison of two assays (EIA and EITB) and two samples (saliva and serum) for the diagnosis of neurocysticercosis,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 84, no. 4, pp. 559–562, 1990. View at Publisher · View at Google Scholar · View at Scopus
  93. C. R. Almeida, E. P. Ojopi, C. M. Nunes et al., “Taenia solium DNA is present in the cerebrospinal fluid of neurocysticercosis patients and can be used for diagnosis,” European Archives of Psychiatry and Clinical Neuroscience, vol. 256, no. 5, pp. 307–310, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. A. Plancarte, M. Fexas, and A. Flisser, “Reactivity in ELISA and dot blot of purified GP24, an immunodominant antigen of Taenia solium, for the diagnosis of human neurocysticercosis,” International Journal for Parasitology, vol. 24, no. 5, pp. 733–738, 1994. View at Publisher · View at Google Scholar · View at Scopus
  95. E. Ferrer, L. M. González, J. Á. Martínez-Escribano et al., “Evaluation of recombinant HP6-Tsag, an 18 kDa Taenia saginata oncospheral adhesion protein, for the diagnosis of cysticercosis,” Parasitology Research, vol. 101, no. 3, pp. 517–525, 2007. View at Publisher · View at Google Scholar · View at PubMed
  96. W. W. Gibbs, “Nanobodies,” Scientific American, vol. 293, no. 2, pp. 78–83, 2005. View at Scopus
  97. N. Deckers, D. Saerens, K. Kanobana et al., “Nanobodies, a promising tool for species-specific diagnosis of Taenia solium cysticercosis,” International Journal for Parasitology, vol. 39, no. 5, pp. 625–633, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  98. L. Ratier, M. Urrutia, G. Paris, L. Zarebski, A. C. Frasch, and F. A. Goldbaum, “Relevance of the diversity among members of the Trypanosoma cruzi trans-sialidase family analyzed with camelids single-domain antibodies,” PLoS ONE, vol. 3, no. 10, Article ID e3524, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  99. K. A. Henderson, V. A. Streltsov, A. M. Coley et al., “Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition,” Structure, vol. 15, no. 11, pp. 1452–1466, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  100. J. Wesolowski, V. Alzogaray, J. Reyelt et al., “Single domain antibodies: promising experimental and therapeutic tools in infection and immunity,” Medical Microbiology and Immunology, vol. 198, no. 3, pp. 157–174, 2009. View at Publisher · View at Google Scholar · View at PubMed
  101. T. Corona, D. Pascoe, and D. Gonzalez-Barranco, “Anticysticercous antibodies in serum and cerebrospinal fluid in patients with cerebral cysticercosis,” Journal of Neurology Neurosurgery and Psychiatry, vol. 49, no. 9, pp. 1044–1049, 1986.
  102. I. N. Mohammad, D. C. Heiner, B. L. Miller, M. A. Goldberg, and I. G. Kagan, “Enzyme-linked immunosorbent assay for the diagnosis of cerebral cysticercosis,” Journal of Clinical Microbiology, vol. 20, no. 4, pp. 775–779, 1984.
  103. N. Rosas, J. Sotelo, and D. Nieto, “ELISA in the diagnosis of neurocysticercosis,” Archives of Neurology, vol. 43, no. 4, pp. 353–356, 1986. View at Scopus
  104. D. Zini, V. J.R. Farrell, and A. A. Wadee, “The relationship of antibody levels to the clinical spectrum of human neurocysticercosis,” Journal of Neurology Neurosurgery and Psychiatry, vol. 53, no. 8, pp. 656–661, 1990.
  105. E. G. Lee, Y. A. Bae, S. H. Kim, S. P. Díaz-Camacho, Y. Nawa, and Y. Kong, “Serodiagnostic reliability of single-step enriched low-molecular weight proteins of Taenia solium metacestode of American and Asian isolates,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 104, no. 10, pp. 676–683, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  106. S. Handali, M. Klarman, A. N. Gaspard et al., “Multiantigen print immunoassay for comparison of diagnostic antigens for Taenia solium cysticercosis and taeniasis,” Clinical and Vaccine Immunology, vol. 17, no. 1, pp. 68–72, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  107. T. Schmitz, U. Felderhoff-Mueser, M. Sifringer, F. Groenendaal, S. Kampmann, and A. Heep, “Expression of soluble Fas in the cerebrospinal fluid of preterm infants with posthemorrhagic hydrocephalus and cystic white matter damage,” Journal of Perinatal Medicine, vol. 39, no. 1, pp. 83–88, 2011. View at Publisher · View at Google Scholar · View at PubMed
  108. R. L. Hayes, G. Robinson, U. Muller, and K. K. Wang, “Translation of neurological biomarkers to clinically relevant platforms,” Methods in Molecular Biology, vol. 566, pp. 303–313, 2009. View at Publisher · View at Google Scholar · View at Scopus